Comprehensive In Vitro Metabolic Characterization of Eudesmin in Human and Mouse Hepatocytes
Pharmaceutics · 31.03.2026 · 18 (4) · 432
DOI: 10.3390/pharmaceutics18040432 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 31.03.2026. Verfasst von Min Seo Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, The Catholic University of Korea, Bucheon 14662, Republic of Korea. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, The Catholic University of Korea, Yeungnam University.
Abstract (Originalsprache)
Background/Objectives: Eudesmin is a tetrahydrofurofuranoid lignan known for its diverse pharmacological activities, including anti-tumor, anti-inflammatory, and neuroprotective effects. However, its metabolism has not been well characterized.
Methods
This study examined the in vitro metabolism of eudesmin using human and mouse hepatocytes, human liver microsomes, and recombinant drug-metabolizing enzymes. Liquid chromatography–high-resolution mass spectrometry combined with ion identity molecular networking enabled the comprehensive visualization and annotation of eudesmin metabolites.
Results
Eudesmin exhibited moderate metabolic stability in human and mouse hepatocytes, with half-lives of 181.0 min and 132.9 min, and intrinsic clearance values of 27.7 mL/min/kg and 154.0 mL/min/kg, respectively. Incubation of eudesmin with human hepatocytes resulted in the formation of 13 metabolites, including five phase I metabolites (M1–M5) and eight phase II conjugates. Phase I metabolism was dominated by O-demethylation of the 3,4-dimethoxyphenyl moieties, yielding mono-O-demethylated (M1 and M2) and di-O-demethylated metabolites (M3 and M4), as well as a hydroxylated metabolite (M5). Enzyme phenotyping, kinetic analyses, and chemical inhibition experiments identified cytochrome P450 2C9 (CYP2C9) as the major contributor to O-demethylation, with additional contributions from CYP2C19, CYP2C8, CYP3A4, and CYP3A5, whereas hydroxylation was mediated primarily by CYP3A4 and CYP3A5. The O-demethylated metabolites subsequently underwent phase II metabolism, forming glucuronide conjugates of M1–M4 and sulfate conjugates of M1–M3, including a disulfate of M3. Uridine 5′-diphospho-glucuronosyltransferase and sulfotransferase screening revealed the involvement of multiple conjugative enzymes, indicating extensive and distributed phase II metabolism. Specifically, di-O-demethylated metabolites and their conjugates were detected in human hepatocytes but not in mouse hepatocytes, suggesting that the sequential O-demethylation pathway is limited in mice.
Conclusions
This study characterizes eudesmin metabolism, with CYP2C9-mediated O-demethylation and significant species differences between humans and mice, and provides a basis for its further pharmaceutical development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
- College of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea.
- BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit, Vessel-Organ Interaction Research Center (VOICE), Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National Univers…
ORCID-Profile: Min Seo Lee, Ju-Hyun Kim, Im-Sook Song, Yong-Yeon Cho, Joo Young Lee, Hye Suk Lee
Förderung
- National Research Foundation of Korea
- The Catholic University of Korea
- Yeungnam University
- Korea government
- Research Fund of The Catholic University of Korea
- 2023 Yeungnam University Research Grant
Zitieren
APA
Lee, M. S., Kim, J. H., Song, I. S., Cho, Y. Y., Lee, J. Y., & Lee, H. S. (2026). Comprehensive In Vitro Metabolic Characterization of Eudesmin in Human and Mouse Hepatocytes. Pharmaceutics, 18(4), 432. https://doi.org/10.3390/pharmaceutics18040432
Vancouver
Lee MS, Kim JH, Song IS, Cho YY, Lee JY, Lee HS. Comprehensive In Vitro Metabolic Characterization of Eudesmin in Human and Mouse Hepatocytes. Pharmaceutics. 2026;18(4):432. doi:10.3390/pharmaceutics18040432
BibTeX
@article{Lee2026,
author = {Lee, Min Seo and Kim, Ju-Hyun and Song, Im-Sook and Cho, Yong-Yeon and Lee, Joo Young and Lee, Hye Suk},
title = {Comprehensive In Vitro Metabolic Characterization of Eudesmin in Human and Mouse Hepatocytes},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {4},
pages = {432},
doi = {10.3390/pharmaceutics18040432}
}
EUVIMED